COMMUNIQUÉS West-GlobeNewswire

Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
08/01/2026
WESTLAKE VILLAGE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an underwritten public offering [...]
Akari Therapeutics to Present at the 2026 Biotech Showcase
08/01/2026
In-person presentation on Tuesday, January 13 th at 9:30 AM PT As part of the presentation, Mr. Gaslightwala will provide an overview of Akari’s ADC platform, strategic priorities and key milestones for 2026 TAMPA, Fla [...]
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT
08/01/2026
TAIZHOU, China, Jan. 08, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, [...]
Recovery First Treatment Center Names Executive Director With 25 Years of Behavioral Healthcare Leadership
08/01/2026
HOLLYWOOD, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Recovery First Treatment Center, a Florida drug treatment center , has named Scott Frankel as Executive Director. Frankel is a healthcare executive with over 25 years [...]
Apella Raises $80 Million to Transform the Hospital with Ambient AI and Computer Vision
08/01/2026
The company has supported 500,000 surgical cases to date; strategic investment will fuel expansion to new health systems SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Apella , a health technology company, today [...]
Dewpoint Therapeutics Announces TDP-43 Condensate Modulator Development Candidate for Treatment of ALS and Related Neurodegenerative Diseases
08/01/2026
First-in-class condensate-modulating small molecule Development Candidate targeting pathogenic TDP-43 condensates. Restores global TDP-43 splicing function in disease-relevant systems. Demonstrates in vivo activity in [...]
ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026
08/01/2026
TYLER, Texas, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in non-invasive therapeutic [...]
Argobio launches Enodia with €20.7 million seed financing to advance a small molecule platform for targeted protein degradation enabled by proteomics and machine learning
08/01/2026
Argobio successfully facilitated fundraising and syndication process, following its earlier role in creating and pre-seed funding Enodia Financing co-led by Elaia, Pfizer Ventures and Bpifrance Enodia is the third [...]
Ontario Shores Launches North America’s First Recovery High School Program for Youth Mental Health
08/01/2026
Whitby, Ontario, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Ontario Shores Centre for Mental Health Sciences (Ontario Shores) has opened North America’s first Recovery High School , giving students with mental health challenges [...]
LucyRx Appoints Christin Bassett as Chief Legal Officer
08/01/2026
Bassett brings deep PBM regulatory and compliance expertise to support rapid growth BETHESDA, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- LucyRx, an independent pharmacy benefit manager (PBM) known for simplifying access to [...]
ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
08/01/2026
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat [...]
ALK to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco
08/01/2026
ALK ( ALKB:DC / OMX: ALK B ) today announced that the company’s president & CEO, Peter Halling, is scheduled to give a company presentation at the 44 th Annual J.P. Morgan Healthcare Conference in San Francisco on [...]
Vystar Corp. Submits Binding Letter of Intent to Acquire Stake in GoPaid.com LLC and Form Strategic Partnership with Capital R3alm to Launch R3alm Oracle and R3alm Collectibles
08/01/2026
Worcester, Massachusetts, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Vystar Corporation (OTCQB: VYST ), a diversified innovation company with operations spanning eco-friendly products and collectibles monetization, today [...]
Easy Environmental Solutions Enters 2026 With Accelerated Global Momentum and a Clear Path to Scale
08/01/2026
Company surpasses 2025 international development targets and advances toward multi-continent deployment of disruptive integrated soil and water technologies MANKATO, Minn., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Easy [...]
MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease
08/01/2026
Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation Award Expands iNKT platform into transplantation with an off-the-shelf, HLA-independent, lymphodepletion-free [...]
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
08/01/2026
GAITHERSBURG, Md. and PARIS and ADDIS ABABA, Ethiopia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) announced a collaboration agreement with PANTHER to provide additional financial support [...]
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights
08/01/2026
Pooled patients treated with TTI-101 demonstrated a 9.4% decrease from baseline in fibrosis score at week 12, compared to a 2.4% decrease for the placebo group Topline healthy volunteer data from Phase 1 study of next- [...]
Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome
08/01/2026
Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from FORWARD Trial Planned in 2026 BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE [...]
Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer
08/01/2026
KUALA LUMPUR, Malaysia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (NASDAQ: ALPS) (the “Company” or “Alps Group”), a fully integrated biotechnology research and healthcare platform specializing in predictive, [...]

Pages